Dr. Simon Kimm

Dr. Simon Kimm
Dr. Kimm graduated from the Honors Program in Medical Education at Northwestern University, where he conducted basic science research in disorders of the prostate, and was awarded an American Foundation of Urologic Diseases Fellowship. He was accepted into the Stanford University Medical Center residency program in Urology, serving as chief resident from 2010-2011. For three years he served as a Clinical Instructor and Fellow in Urologic Oncology at Memorial Sloan-Kettering Cancer Center in New York. Every day I strive to treat my patients the way I would want my family and loved ones to be treated. We deserve care that is well communicated and coordinated; utilizing all the advances modern medicine has to offer. I believe the best health and wellness outcomes occur when there is a strong partnership between the patient and physician, with open lines of communication and transparent collaboration between experts. This care should go beyond just finding illness and treating it, but should foster a sense of well-being and empowerment over your health.
Medical School:

Northwestern University Feinberg School of Medicine

Residency:

Stanford University Medical Center, General Surgery & Urology

Fellowship:

Urologic Oncology, Memorial Sloan Kettering Cancer Center

Locations

Palo Alto Medical Foundation Dublin, CA

4000 Dublin Blvd, Floor 2Dublin, California, 94568United States
510-498-2886 | Visit Website

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only